MassiveID	filename	SampleType	SampleTypeSub1	NCBITaxonomy	YearOfAnalysis	SampleCollectionMethod	SampleExtractionMethod	InternalStandardsUsed	MassSpectrometer	IonizationSourceAndPolarity	ChromatographyAndPhase	SubjectIdentifierAsRecorded	AgeInYears	BiologicalSex	UBERONBodyPartName	TermsofPosition	HealthStatus	DOIDCommonName	ComorbidityListDOIDIndex	SampleCollectionDateandTime	Country	HumanPopulationDensity	LatitudeandLongitude	DepthorAltitudeMeters	qiita_sample_name	UniqueSubjectID	LifeStage	UBERONOntologyIndex	DOIDOntologyIndex	ATTRIBUTE_Diet	id
MSV000094097	Blank_3_blood.mzML	blank_analysis	blank_analysis	not applicable	2023	not applicable	methanol-water (1:1)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	not applicable	not applicable	not applicable		United States of America	not collected						not applicable	not applicable	not applicable	0
MSV000094097	Blank_3_prot2_saliva.mzML	blank_analysis	blank_analysis	not applicable	2023	not applicable	methanol-water (1:1)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	not applicable	not applicable	not applicable		United States of America	not collected						not applicable	not applicable	not applicable	1
MSV000094097	Blank_3_stool.mzML	blank_analysis	blank_analysis	not applicable	2023	not applicable	methanol-water (1:1)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	not applicable	not applicable	not applicable		United States of America	not collected						not applicable	not applicable	not applicable	2
MSV000094097	Blank_4_blood.mzML	blank_analysis	blank_analysis	not applicable	2023	not applicable	methanol-water (1:1)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	not applicable	not applicable	not applicable		United States of America	not collected						not applicable	not applicable	not applicable	3
MSV000094097	Blank_4_prot2_saliva.mzML	blank_analysis	blank_analysis	not applicable	2023	not applicable	methanol-water (1:1)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	not applicable	not applicable	not applicable		United States of America	not collected						not applicable	not applicable	not applicable	4
MSV000094097	Blank_4_stool.mzML	blank_analysis	blank_analysis	not applicable	2023	not applicable	methanol-water (1:1)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	not applicable	not applicable	not applicable		United States of America	not collected						not applicable	not applicable	not applicable	5
MSV000094097	Blank_5_prot2_saliva.mzML	blank_analysis	blank_analysis	not applicable	2023	not applicable	methanol-water (1:1)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	not applicable	not applicable	not applicable		United States of America	not collected						not applicable	not applicable	not applicable	6
MSV000094097	Blank_5_stool.mzML	blank_analysis	blank_analysis	not applicable	2023	not applicable	methanol-water (1:1)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	not applicable	not applicable	not applicable		United States of America	not collected						not applicable	not applicable	not applicable	7
MSV000094097	Blank_6_blood.mzML	blank_analysis	blank_analysis	not applicable	2023	not applicable	methanol-water (1:1)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	not applicable	not applicable	not applicable		United States of America	not collected						not applicable	not applicable	not applicable	8
MSV000094097	Blank_6_prot2_saliva.mzML	blank_analysis	blank_analysis	not applicable	2023	not applicable	methanol-water (1:1)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	not applicable	not applicable	not applicable		United States of America	not collected						not applicable	not applicable	not applicable	9
MSV000094097	Blank_6_stool.mzML	blank_analysis	blank_analysis	not applicable	2023	not applicable	methanol-water (1:1)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	not applicable	not applicable	not applicable		United States of America	not collected						not applicable	not applicable	not applicable	10
MSV000094097	Blank_7_blood.mzML	blank_analysis	blank_analysis	not applicable	2023	not applicable	methanol-water (1:1)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	not applicable	not applicable	not applicable		United States of America	not collected						not applicable	not applicable	not applicable	11
MSV000094097	Blank_7_prot2_saliva.mzML	blank_analysis	blank_analysis	not applicable	2023	not applicable	methanol-water (1:1)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	not applicable	not applicable	not applicable		United States of America	not collected						not applicable	not applicable	not applicable	12
MSV000094097	Blank_7_stool.mzML	blank_analysis	blank_analysis	not applicable	2023	not applicable	methanol-water (1:1)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	not applicable	not applicable	not applicable		United States of America	not collected						not applicable	not applicable	not applicable	13
MSV000094097	Blank_8_blood.mzML	blank_analysis	blank_analysis	not applicable	2023	not applicable	methanol-water (1:1)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	not applicable	not applicable	not applicable		United States of America	not collected						not applicable	not applicable	not applicable	14
MSV000094097	Blank_8_prot2_saliva.mzML	blank_analysis	blank_analysis	not applicable	2023	not applicable	methanol-water (1:1)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	not applicable	not applicable	not applicable		United States of America	not collected						not applicable	not applicable	not applicable	15
MSV000094097	Blank_8_stool.mzML	blank_analysis	blank_analysis	not applicable	2023	not applicable	methanol-water (1:1)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	not applicable	not applicable	not applicable		United States of America	not collected						not applicable	not applicable	not applicable	16
MSV000094097	Blank_9_blood.mzML	blank_analysis	blank_analysis	not applicable	2023	not applicable	methanol-water (1:1)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	not applicable	not applicable	not applicable		United States of America	not collected						not applicable	not applicable	not applicable	17
MSV000094097	Blank_9_prot2_saliva.mzML	blank_analysis	blank_analysis	not applicable	2023	not applicable	methanol-water (1:1)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	not applicable	not applicable	not applicable		United States of America	not collected						not applicable	not applicable	not applicable	18
MSV000094097	Blank_9_stool.mzML	blank_analysis	blank_analysis	not applicable	2023	not applicable	methanol-water (1:1)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	not applicable	not applicable	not applicable		United States of America	not collected						not applicable	not applicable	not applicable	19
MSV000094097	Blank_10_blood.mzML	blank_analysis	blank_analysis	not applicable	2023	not applicable	methanol-water (1:1)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	not applicable	not applicable	not applicable		United States of America	not collected						not applicable	not applicable	not applicable	20
MSV000094097	Blank_10_prot2_saliva.mzML	blank_analysis	blank_analysis	not applicable	2023	not applicable	methanol-water (1:1)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	not applicable	not applicable	not applicable		United States of America	not collected						not applicable	not applicable	not applicable	21
MSV000094097	Blank_10_stool.mzML	blank_analysis	blank_analysis	not applicable	2023	not applicable	methanol-water (1:1)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	not applicable	not applicable	not applicable		United States of America	not collected						not applicable	not applicable	not applicable	22
MSV000094097	Blank_11_blood.mzML	blank_analysis	blank_analysis	not applicable	2023	not applicable	methanol-water (1:1)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	not applicable	not applicable	not applicable		United States of America	not collected						not applicable	not applicable	not applicable	23
MSV000094097	Blank_11_prot2_saliva.mzML	blank_analysis	blank_analysis	not applicable	2023	not applicable	methanol-water (1:1)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	not applicable	not applicable	not applicable		United States of America	not collected						not applicable	not applicable	not applicable	24
MSV000094097	Blank_11_stool.mzML	blank_analysis	blank_analysis	not applicable	2023	not applicable	methanol-water (1:1)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	not applicable	not applicable	not applicable		United States of America	not collected						not applicable	not applicable	not applicable	25
MSV000094097	Blank_12_blood.mzML	blank_analysis	blank_analysis	not applicable	2023	not applicable	methanol-water (1:1)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	not applicable	not applicable	not applicable		United States of America	not collected						not applicable	not applicable	not applicable	26
MSV000094097	Blank_12_stool.mzML	blank_analysis	blank_analysis	not applicable	2023	not applicable	methanol-water (1:1)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	not applicable	not applicable	not applicable		United States of America	not collected						not applicable	not applicable	not applicable	27
MSV000094097	Blank_13_blood.mzML	blank_analysis	blank_analysis	not applicable	2023	not applicable	methanol-water (1:1)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	not applicable	not applicable	not applicable		United States of America	not collected						not applicable	not applicable	not applicable	28
MSV000094097	Blank_13_prot2_saliva.mzML	blank_analysis	blank_analysis	not applicable	2023	not applicable	methanol-water (1:1)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	not applicable	not applicable	not applicable		United States of America	not collected						not applicable	not applicable	not applicable	29
MSV000094097	Blank_13_stool.mzML	blank_analysis	blank_analysis	not applicable	2023	not applicable	methanol-water (1:1)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	not applicable	not applicable	not applicable		United States of America	not collected						not applicable	not applicable	not applicable	30
MSV000094097	Blank_14_blood.mzML	blank_analysis	blank_analysis	not applicable	2023	not applicable	methanol-water (1:1)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	not applicable	not applicable	not applicable		United States of America	not collected						not applicable	not applicable	not applicable	31
MSV000094097	Blank_14_prot2_saliva.mzML	blank_analysis	blank_analysis	not applicable	2023	not applicable	methanol-water (1:1)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	not applicable	not applicable	not applicable		United States of America	not collected						not applicable	not applicable	not applicable	32
MSV000094097	Blank_14_stool.mzML	blank_analysis	blank_analysis	not applicable	2023	not applicable	methanol-water (1:1)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	not applicable	not applicable	not applicable		United States of America	not collected						not applicable	not applicable	not applicable	33
MSV000094097	Blank_15_blood.mzML	blank_analysis	blank_analysis	not applicable	2023	not applicable	methanol-water (1:1)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	not applicable	not applicable	not applicable		United States of America	not collected						not applicable	not applicable	not applicable	34
MSV000094097	Blank_15_prot2_saliva.mzML	blank_analysis	blank_analysis	not applicable	2023	not applicable	methanol-water (1:1)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	not applicable	not applicable	not applicable		United States of America	not collected						not applicable	not applicable	not applicable	35
MSV000094097	Blank_15_stool.mzML	blank_analysis	blank_analysis	not applicable	2023	not applicable	methanol-water (1:1)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	not applicable	not applicable	not applicable		United States of America	not collected						not applicable	not applicable	not applicable	36
MSV000094097	Blank_16_blood.mzML	blank_analysis	blank_analysis	not applicable	2023	not applicable	methanol-water (1:1)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	not applicable	not applicable	not applicable		United States of America	not collected						not applicable	not applicable	not applicable	37
MSV000094097	Blank_16_stool.mzML	blank_analysis	blank_analysis	not applicable	2023	not applicable	methanol-water (1:1)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	not applicable	not applicable	not applicable		United States of America	not collected						not applicable	not applicable	not applicable	38
MSV000094097	Blank_17_blood.mzML	blank_analysis	blank_analysis	not applicable	2023	not applicable	methanol-water (1:1)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	not applicable	not applicable	not applicable		United States of America	not collected						not applicable	not applicable	not applicable	39
MSV000094097	Blank_17_prot2_saliva.mzML	blank_analysis	blank_analysis	not applicable	2023	not applicable	methanol-water (1:1)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	not applicable	not applicable	not applicable		United States of America	not collected						not applicable	not applicable	not applicable	40
MSV000094097	Blank_17_stool.mzML	blank_analysis	blank_analysis	not applicable	2023	not applicable	methanol-water (1:1)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	not applicable	not applicable	not applicable		United States of America	not collected						not applicable	not applicable	not applicable	41
MSV000094097	Blank_18_blood.mzML	blank_analysis	blank_analysis	not applicable	2023	not applicable	methanol-water (1:1)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	not applicable	not applicable	not applicable		United States of America	not collected						not applicable	not applicable	not applicable	42
MSV000094097	Blank_18_prot2_saliva.mzML	blank_analysis	blank_analysis	not applicable	2023	not applicable	methanol-water (1:1)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	not applicable	not applicable	not applicable		United States of America	not collected						not applicable	not applicable	not applicable	43
MSV000094097	Blank_18_stool.mzML	blank_analysis	blank_analysis	not applicable	2023	not applicable	methanol-water (1:1)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	not applicable	not applicable	not applicable		United States of America	not collected						not applicable	not applicable	not applicable	44
MSV000094097	Blank_19_blood.mzML	blank_analysis	blank_analysis	not applicable	2023	not applicable	methanol-water (1:1)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	not applicable	not applicable	not applicable		United States of America	not collected						not applicable	not applicable	not applicable	45
MSV000094097	Blank_20_blood.mzML	blank_analysis	blank_analysis	not applicable	2023	not applicable	methanol-water (1:1)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	not applicable	not applicable	not applicable		United States of America	not collected						not applicable	not applicable	not applicable	46
MSV000094097	Blank_21_blood.mzML	blank_analysis	blank_analysis	not applicable	2023	not applicable	methanol-water (1:1)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	not applicable	not applicable	not applicable		United States of America	not collected						not applicable	not applicable	not applicable	47
MSV000094097	Blank_22_blood.mzML	blank_analysis	blank_analysis	not applicable	2023	not applicable	methanol-water (1:1)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	not applicable	not applicable	not applicable		United States of America	not collected						not applicable	not applicable	not applicable	48
MSV000094097	Blank_23_blood.mzML	blank_analysis	blank_analysis	not applicable	2023	not applicable	methanol-water (1:1)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	not applicable	not applicable	not applicable		United States of America	not collected						not applicable	not applicable	not applicable	49
MSV000094097	control_1_prot2_saliva.mzML	blank_extraction	blank_extraction	not applicable	2023	not applicable	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	not applicable	not applicable	not applicable		United States of America	not collected						not applicable	not applicable	not applicable	50
MSV000094097	control_1_stool.mzML	blank_extraction	blank_extraction	not applicable	2023	not applicable	ethanol-water (1:1)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	not applicable	not applicable	not applicable		United States of America	not collected						not applicable	not applicable	not applicable	51
MSV000094097	control_2_prot2_saliva.mzML	blank_extraction	blank_extraction	not applicable	2023	not applicable	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	not applicable	not applicable	not applicable		United States of America	not collected						not applicable	not applicable	not applicable	52
MSV000094097	control_2_stool.mzML	blank_extraction	blank_extraction	not applicable	2023	not applicable	ethanol-water (1:1)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	not applicable	not applicable	not applicable		United States of America	not collected						not applicable	not applicable	not applicable	53
MSV000094097	control_3_prot2_saliva.mzML	blank_extraction	blank_extraction	not applicable	2023	not applicable	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	not applicable	not applicable	not applicable		United States of America	not collected						not applicable	not applicable	not applicable	54
MSV000094097	control_3_stool.mzML	blank_extraction	blank_extraction	not applicable	2023	not applicable	ethanol-water (1:1)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	not applicable	not applicable	not applicable		United States of America	not collected						not applicable	not applicable	not applicable	55
MSV000094097	OAD_001_Basal_P.mzML	animal	biofluid	9606|Homo sapiens	2023	blood draw, venous	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		64.0	female	blood plasma	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969		Before	56
MSV000094097	OAD_001_Basal_S.mzML	animal	biofluid	9606|Homo sapiens	2023	blood draw, venous	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		64.0	female	blood serum	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001977		Before	57
MSV000094097	OAD_001_Day15_P.mzML	animal	biofluid	9606|Homo sapiens	2023	blood draw, venous	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		64.0	female	blood plasma	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969		After	58
MSV000094097	OAD_001_Day15_S.mzML	animal	biofluid	9606|Homo sapiens	2023	blood draw, venous	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		64.0	female	blood serum	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001977		After	59
MSV000094097	OAD_003_Basal_P.mzML	animal	biofluid	9606|Homo sapiens	2023	blood draw, venous	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		56.0	female	blood plasma	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969		Before	60
MSV000094097	OAD_003_Basal_S.mzML	animal	biofluid	9606|Homo sapiens	2023	blood draw, venous	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		56.0	female	blood serum	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001977		Before	61
MSV000094097	OAD_003_Day15_P.mzML	animal	biofluid	9606|Homo sapiens	2023	blood draw, venous	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		56.0	female	blood plasma	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969		After	62
MSV000094097	OAD_003_Day15_S.mzML	animal	biofluid	9606|Homo sapiens	2023	blood draw, venous	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		56.0	female	blood serum	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001977		After	63
MSV000094097	OAD_004_Basal_P.mzML	animal	biofluid	9606|Homo sapiens	2023	blood draw, venous	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		69.0	female	blood plasma	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Later Adulthood (>65 yrs)	UBERON:0001969		Before	64
MSV000094097	OAD_004_Basal_S.mzML	animal	biofluid	9606|Homo sapiens	2023	blood draw, venous	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		69.0	female	blood serum	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Later Adulthood (>65 yrs)	UBERON:0001977		Before	65
MSV000094097	OAD_004_Day15_P.mzML	animal	biofluid	9606|Homo sapiens	2023	blood draw, venous	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		69.0	female	blood plasma	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Later Adulthood (>65 yrs)	UBERON:0001969		After	66
MSV000094097	OAD_005_Basal_P.mzML	animal	biofluid	9606|Homo sapiens	2023	blood draw, venous	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		74.0	male	blood plasma	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Later Adulthood (>65 yrs)	UBERON:0001969		Before	67
MSV000094097	OAD_005_Basal_S.mzML	animal	biofluid	9606|Homo sapiens	2023	blood draw, venous	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		74.0	male	blood serum	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Later Adulthood (>65 yrs)	UBERON:0001977		Before	68
MSV000094097	OAD_005_Day15_P_2.mzML	animal	biofluid	9606|Homo sapiens	2023	blood draw, venous	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		74.0	male	blood plasma	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Later Adulthood (>65 yrs)	UBERON:0001969		After	69
MSV000094097	OAD_005_Day15_S.mzML	animal	biofluid	9606|Homo sapiens	2023	blood draw, venous	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		74.0	male	blood serum	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Later Adulthood (>65 yrs)	UBERON:0001977		After	70
MSV000094097	OAD_006_Basal_P.mzML	animal	biofluid	9606|Homo sapiens	2023	blood draw, venous	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		59.0	female	blood plasma	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969		Before	71
MSV000094097	OAD_006_Basal_S.mzML	animal	biofluid	9606|Homo sapiens	2023	blood draw, venous	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		59.0	female	blood serum	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001977		Before	72
MSV000094097	OAD_006_Day15_P.mzML	animal	biofluid	9606|Homo sapiens	2023	blood draw, venous	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		59.0	female	blood plasma	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969		After	73
MSV000094097	OAD_006_Day15_S.mzML	animal	biofluid	9606|Homo sapiens	2023	blood draw, venous	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		59.0	female	blood serum	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001977		After	74
MSV000094097	OAD_007_Basal_P.mzML	animal	biofluid	9606|Homo sapiens	2023	blood draw, venous	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		57.0	female	blood plasma	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969		Before	75
MSV000094097	OAD_007_Basal_S.mzML	animal	biofluid	9606|Homo sapiens	2023	blood draw, venous	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		57.0	female	blood serum	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001977		Before	76
MSV000094097	OAD_007_Day15_P.mzML	animal	biofluid	9606|Homo sapiens	2023	blood draw, venous	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		57.0	female	blood plasma	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969		After	77
MSV000094097	OAD_007_Day15_S.mzML	animal	biofluid	9606|Homo sapiens	2023	blood draw, venous	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		57.0	female	blood serum	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001977		After	78
MSV000094097	OAD_008_Basal_P.mzML	animal	biofluid	9606|Homo sapiens	2023	blood draw, venous	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		53.0	female	blood plasma	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969		Before	79
MSV000094097	OAD_008_Basal_S.mzML	animal	biofluid	9606|Homo sapiens	2023	blood draw, venous	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		53.0	female	blood serum	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001977		Before	80
MSV000094097	OAD_008_Day15_P.mzML	animal	biofluid	9606|Homo sapiens	2023	blood draw, venous	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		53.0	female	blood plasma	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969		After	81
MSV000094097	OAD_008_Day15_S.mzML	animal	biofluid	9606|Homo sapiens	2023	blood draw, venous	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		53.0	female	blood serum	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001977		After	82
MSV000094097	OAD_009_Basal_P.mzML	animal	biofluid	9606|Homo sapiens	2023	blood draw, venous	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		61.0	female	blood plasma	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969		Before	83
MSV000094097	OAD_009_Basal_S.mzML	animal	biofluid	9606|Homo sapiens	2023	blood draw, venous	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		61.0	female	blood serum	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001977		Before	84
MSV000094097	OAD_009_Day15_P.mzML	animal	biofluid	9606|Homo sapiens	2023	blood draw, venous	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		61.0	female	blood plasma	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969		After	85
MSV000094097	OAD_009_Day15_S.mzML	animal	biofluid	9606|Homo sapiens	2023	blood draw, venous	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		61.0	female	blood serum	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001977		After	86
MSV000094097	OAD_012_Basal_P.mzML	animal	biofluid	9606|Homo sapiens	2023	blood draw, venous	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		71.0	female	blood plasma	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Later Adulthood (>65 yrs)	UBERON:0001969		Before	87
MSV000094097	OAD_012_Basal_S.mzML	animal	biofluid	9606|Homo sapiens	2023	blood draw, venous	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		71.0	female	blood serum	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Later Adulthood (>65 yrs)	UBERON:0001977		Before	88
MSV000094097	OAD_012_Day15_P.mzML	animal	biofluid	9606|Homo sapiens	2023	blood draw, venous	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		71.0	female	blood plasma	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Later Adulthood (>65 yrs)	UBERON:0001969		After	89
MSV000094097	OAD_012_Day15_S.mzML	animal	biofluid	9606|Homo sapiens	2023	blood draw, venous	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		71.0	female	blood serum	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Later Adulthood (>65 yrs)	UBERON:0001977		After	90
MSV000094097	OAD_013_Basal_P.mzML	animal	biofluid	9606|Homo sapiens	2023	blood draw, venous	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		60.0	female	blood plasma	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969		Before	91
MSV000094097	OAD_013_Basal_S.mzML	animal	biofluid	9606|Homo sapiens	2023	blood draw, venous	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		60.0	female	blood serum	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001977		Before	92
MSV000094097	OAD_013_Day15_P.mzML	animal	biofluid	9606|Homo sapiens	2023	blood draw, venous	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		60.0	female	blood plasma	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969		After	93
MSV000094097	OAD_013_Day15_S.mzML	animal	biofluid	9606|Homo sapiens	2023	blood draw, venous	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		60.0	female	blood serum	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001977		After	94
MSV000094097	OAD_017_Basal_P.mzML	animal	biofluid	9606|Homo sapiens	2023	blood draw, venous	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		72.0	female	blood plasma	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Later Adulthood (>65 yrs)	UBERON:0001969		Before	95
MSV000094097	OAD_017_Basal_S.mzML	animal	biofluid	9606|Homo sapiens	2023	blood draw, venous	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		72.0	female	blood serum	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Later Adulthood (>65 yrs)	UBERON:0001977		Before	96
MSV000094097	OAD_017_Day15_P.mzML	animal	biofluid	9606|Homo sapiens	2023	blood draw, venous	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		72.0	female	blood plasma	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Later Adulthood (>65 yrs)	UBERON:0001969		After	97
MSV000094097	OAD_017_Day15_S.mzML	animal	biofluid	9606|Homo sapiens	2023	blood draw, venous	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		72.0	female	blood serum	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Later Adulthood (>65 yrs)	UBERON:0001977		After	98
MSV000094097	OAS_1_saliva_prot2.mzML	animal	biofluid	9606|Homo sapiens	2023	liquid	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		72.0	male	saliva	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Later Adulthood (>65 yrs)	UBERON:0001836		Before	99
MSV000094097	OAS_1_stool.mzML	animal	biofluid	9606|Homo sapiens	2023	swabs, solution (100% EtOH)	ethanol-water (1:1)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		72.0	male	feces	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Later Adulthood (>65 yrs)	UBERON:0001988		Before	100
MSV000094097	OAS_2_saliva_prot2.mzML	animal	biofluid	9606|Homo sapiens	2023	liquid	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		72.0	male	saliva	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Later Adulthood (>65 yrs)	UBERON:0001836		After	101
MSV000094097	OAS_2_stool.mzML	animal	biofluid	9606|Homo sapiens	2023	swabs, solution (100% EtOH)	ethanol-water (1:1)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		72.0	female	feces	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Later Adulthood (>65 yrs)	UBERON:0001988		After	102
MSV000094097	OAS_3_saliva_prot2.mzML	animal	biofluid	9606|Homo sapiens	2023	liquid	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		55.0	female	saliva	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001836		Before	103
MSV000094097	OAS_3_stool.mzML	animal	biofluid	9606|Homo sapiens	2023	swabs, solution (100% EtOH)	ethanol-water (1:1)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		55.0	female	feces	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001988		Before	104
MSV000094097	OAS_4_saliva_prot2.mzML	animal	biofluid	9606|Homo sapiens	2023	liquid	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		55.0	female	saliva	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001836		After	105
MSV000094097	OAS_4_stool.mzML	animal	biofluid	9606|Homo sapiens	2023	swabs, solution (100% EtOH)	ethanol-water (1:1)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		55.0	female	feces	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001988		After	106
MSV000094097	OAS_5_saliva_prot2.mzML	animal	biofluid	9606|Homo sapiens	2023	liquid	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		71.0	male	saliva	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Later Adulthood (>65 yrs)	UBERON:0001836		Before	107
MSV000094097	OAS_5_stool.mzML	animal	biofluid	9606|Homo sapiens	2023	swabs, solution (100% EtOH)	ethanol-water (1:1)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		71.0	male	feces	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Later Adulthood (>65 yrs)	UBERON:0001988		Before	108
MSV000094097	OAS_6_saliva_prot2.mzML	animal	biofluid	9606|Homo sapiens	2023	liquid	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		71.0	male	saliva	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Later Adulthood (>65 yrs)	UBERON:0001836		After	109
MSV000094097	OAS_6_stool_inj3.mzML	animal	biofluid	9606|Homo sapiens	2023	swabs, solution (100% EtOH)	ethanol-water (1:1)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		71.0	male	feces	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Later Adulthood (>65 yrs)	UBERON:0001988		After	110
MSV000094097	OAS_7_saliva_prot2.mzML	animal	biofluid	9606|Homo sapiens	2023	liquid	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		51.0	male	saliva	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001836		Before	111
MSV000094097	OAS_7_stool.mzML	animal	biofluid	9606|Homo sapiens	2023	swabs, solution (100% EtOH)	ethanol-water (1:1)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		51.0	male	feces	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001988		Before	112
MSV000094097	OAS_8_saliva_prot2.mzML	animal	biofluid	9606|Homo sapiens	2023	liquid	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		51.0	male	saliva	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001836		After	113
MSV000094097	OAS_8_stool_inj2.mzML	animal	biofluid	9606|Homo sapiens	2023	swabs, solution (100% EtOH)	ethanol-water (1:1)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		51.0	male	feces	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001988		After	114
MSV000094097	OAS_9_saliva_prot2.mzML	animal	biofluid	9606|Homo sapiens	2023	liquid	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		68.0	male	saliva	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Later Adulthood (>65 yrs)	UBERON:0001836		Before	115
MSV000094097	OAS_9_stool_inj2.mzML	animal	biofluid	9606|Homo sapiens	2023	swabs, solution (100% EtOH)	ethanol-water (1:1)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		68.0	male	feces	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Later Adulthood (>65 yrs)	UBERON:0001988		Before	116
MSV000094097	OAS_10_saliva_prot2.mzML	animal	biofluid	9606|Homo sapiens	2023	liquid	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		68.0	male	saliva	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Later Adulthood (>65 yrs)	UBERON:0001836		After	117
MSV000094097	OAS_10_stool.mzML	animal	biofluid	9606|Homo sapiens	2023	swabs, solution (100% EtOH)	ethanol-water (1:1)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		68.0	male	feces	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Later Adulthood (>65 yrs)	UBERON:0001988		After	118
MSV000094097	OAS_11_saliva_prot2.mzML	animal	biofluid	9606|Homo sapiens	2023	liquid	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		64.0	female	saliva	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001836		Before	119
MSV000094097	OAS_11_stool.mzML	animal	biofluid	9606|Homo sapiens	2023	swabs, solution (100% EtOH)	ethanol-water (1:1)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		64.0	female	feces	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001988		Before	120
MSV000094097	OAS_12_saliva_prot2.mzML	animal	biofluid	9606|Homo sapiens	2023	liquid	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		64.0	female	saliva	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001836		After	121
MSV000094097	OAS_12_stool.mzML	animal	biofluid	9606|Homo sapiens	2023	swabs, solution (100% EtOH)	ethanol-water (1:1)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		64.0	female	feces	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001988		After	122
MSV000094097	OAS_13_saliva_prot2.mzML	animal	biofluid	9606|Homo sapiens	2023	liquid	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		56.0	female	saliva	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001836		Before	123
MSV000094097	OAS_13_stool.mzML	animal	biofluid	9606|Homo sapiens	2023	swabs, solution (100% EtOH)	ethanol-water (1:1)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		56.0	female	feces	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001988		Before	124
MSV000094097	OAS_14_saliva_prot2.mzML	animal	biofluid	9606|Homo sapiens	2023	liquid	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		56.0	female	saliva	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001836		After	125
MSV000094097	OAS_14_stool.mzML	animal	biofluid	9606|Homo sapiens	2023	swabs, solution (100% EtOH)	ethanol-water (1:1)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		56.0	female	feces	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001988		After	126
MSV000094097	OAS_15_saliva_prot2.mzML	animal	biofluid	9606|Homo sapiens	2023	liquid	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		69.0	female	saliva	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Later Adulthood (>65 yrs)	UBERON:0001836		Before	127
MSV000094097	OAS_15_stool.mzML	animal	biofluid	9606|Homo sapiens	2023	swabs, solution (100% EtOH)	ethanol-water (1:1)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		69.0	female	feces	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Later Adulthood (>65 yrs)	UBERON:0001988		Before	128
MSV000094097	OAS_16_saliva_prot2.mzML	animal	biofluid	9606|Homo sapiens	2023	liquid	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		69.0	female	saliva	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Later Adulthood (>65 yrs)	UBERON:0001836		After	129
MSV000094097	OAS_16_stool.mzML	animal	biofluid	9606|Homo sapiens	2023	swabs, solution (100% EtOH)	ethanol-water (1:1)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		69.0	female	feces	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Later Adulthood (>65 yrs)	UBERON:0001988		After	130
MSV000094097	OAS_17_saliva_prot2.mzML	animal	biofluid	9606|Homo sapiens	2023	liquid	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		65.0	not collected	saliva	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001836		Before	131
MSV000094097	OAS_17_stool_inj2.mzML	animal	biofluid	9606|Homo sapiens	2023	swabs, solution (100% EtOH)	ethanol-water (1:1)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		65.0	not collected	feces	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001988		Before	132
MSV000094097	OAS_18_saliva_prot2.mzML	animal	biofluid	9606|Homo sapiens	2023	liquid	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		65.0	not collected	saliva	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001836		After	133
MSV000094097	OAS_18_stool.mzML	animal	biofluid	9606|Homo sapiens	2023	swabs, solution (100% EtOH)	ethanol-water (1:1)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		65.0	not collected	feces	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001988		After	134
MSV000094097	OAS_19_saliva_prot2.mzML	animal	biofluid	9606|Homo sapiens	2023	liquid	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		74.0	male	saliva	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Later Adulthood (>65 yrs)	UBERON:0001836		Before	135
MSV000094097	OAS_19_stool.mzML	animal	biofluid	9606|Homo sapiens	2023	swabs, solution (100% EtOH)	ethanol-water (1:1)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		74.0	male	feces	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Later Adulthood (>65 yrs)	UBERON:0001988		Before	136
MSV000094097	OAS_20_saliva_prot2_inj2.mzML	animal	biofluid	9606|Homo sapiens	2023	liquid	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		74.0	male	saliva	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Later Adulthood (>65 yrs)	UBERON:0001836		After	137
MSV000094097	OAS_20_stool.mzML	animal	biofluid	9606|Homo sapiens	2023	swabs, solution (100% EtOH)	ethanol-water (1:1)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		74.0	male	feces	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Later Adulthood (>65 yrs)	UBERON:0001988		After	138
MSV000094097	OAS_21_saliva_prot2.mzML	animal	biofluid	9606|Homo sapiens	2023	liquid	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		59.0	female	saliva	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001836		Before	139
MSV000094097	OAS_21_stool.mzML	animal	biofluid	9606|Homo sapiens	2023	swabs, solution (100% EtOH)	ethanol-water (1:1)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		59.0	female	feces	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001988		Before	140
MSV000094097	OAS_22_saliva_prot2.mzML	animal	biofluid	9606|Homo sapiens	2023	liquid	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		59.0	female	saliva	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001836		After	141
MSV000094097	OAS_22_stool_inj2_2uL.mzML	animal	biofluid	9606|Homo sapiens	2023	swabs, solution (100% EtOH)	ethanol-water (1:1)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		59.0	female	feces	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001988		After	142
MSV000094097	OAS_22_stool.mzML	animal	biofluid	9606|Homo sapiens	2023	swabs, solution (100% EtOH)	ethanol-water (1:1)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		59.0	female	feces	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001988		After	143
MSV000094097	OAS_23_saliva_prot2_inj2.mzML	animal	biofluid	9606|Homo sapiens	2023	liquid	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		57.0	female	saliva	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001836		Before	144
MSV000094097	OAS_23_stool.mzML	animal	biofluid	9606|Homo sapiens	2023	swabs, solution (100% EtOH)	ethanol-water (1:1)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		57.0	female	feces	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001988		Before	145
MSV000094097	OAS_24_saliva_prot2_inj2.mzML	animal	biofluid	9606|Homo sapiens	2023	liquid	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		57.0	female	saliva	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001836		After	146
MSV000094097	OAS_24_stool.mzML	animal	biofluid	9606|Homo sapiens	2023	swabs, solution (100% EtOH)	ethanol-water (1:1)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		57.0	female	feces	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001988		After	147
MSV000094097	OAS_25_saliva_prot2_inj2.mzML	animal	biofluid	9606|Homo sapiens	2023	liquid	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		61.0	female	saliva	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001836		Before	148
MSV000094097	OAS_25_stool.mzML	animal	biofluid	9606|Homo sapiens	2023	swabs, solution (100% EtOH)	ethanol-water (1:1)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		61.0	female	feces	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001988		Before	149
MSV000094097	OAS_26_saliva_prot2_inj2.mzML	animal	biofluid	9606|Homo sapiens	2023	liquid	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		61.0	female	saliva	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001836		After	150
MSV000094097	OAS_26_stool.mzML	animal	biofluid	9606|Homo sapiens	2023	swabs, solution (100% EtOH)	ethanol-water (1:1)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		61.0	female	feces	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001988		After	151
MSV000094097	OAS_27_saliva_prot2_inj2.mzML	animal	biofluid	9606|Homo sapiens	2023	liquid	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		71.0	female	saliva	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Later Adulthood (>65 yrs)	UBERON:0001836		Before	152
MSV000094097	OAS_27_stool_inj2.mzML	animal	biofluid	9606|Homo sapiens	2023	swabs, solution (100% EtOH)	ethanol-water (1:1)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		71.0	female	feces	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Later Adulthood (>65 yrs)	UBERON:0001988		Before	153
MSV000094097	OAS_28_saliva_prot2_inj2.mzML	animal	biofluid	9606|Homo sapiens	2023	liquid	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		71.0	female	saliva	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Later Adulthood (>65 yrs)	UBERON:0001836		After	154
MSV000094097	OAS_28_stool_inj2.mzML	animal	biofluid	9606|Homo sapiens	2023	swabs, solution (100% EtOH)	ethanol-water (1:1)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		71.0	female	feces	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Later Adulthood (>65 yrs)	UBERON:0001988		After	155
MSV000094097	OAS_29_saliva_prot2_inj2.mzML	animal	biofluid	9606|Homo sapiens	2023	liquid	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		72.0	female	saliva	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Later Adulthood (>65 yrs)	UBERON:0001836		Before	156
MSV000094097	OAS_29_stool_inj2.mzML	animal	biofluid	9606|Homo sapiens	2023	swabs, solution (100% EtOH)	ethanol-water (1:1)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		72.0	female	feces	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Later Adulthood (>65 yrs)	UBERON:0001988		Before	157
MSV000094097	OAS_30_saliva_prot2_inj2.mzML	animal	biofluid	9606|Homo sapiens	2023	liquid	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		72.0	female	saliva	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Later Adulthood (>65 yrs)	UBERON:0001836		After	158
MSV000094097	OAS_30_stool_inj2.mzML	animal	biofluid	9606|Homo sapiens	2023	swabs, solution (100% EtOH)	ethanol-water (1:1)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		72.0	female	feces	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Later Adulthood (>65 yrs)	UBERON:0001988		After	159
MSV000094097	Pool_blood_plasma_1.mzML	animal	biofluid	9606|Homo sapiens	2023	blood draw, venous	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected						not applicable		not applicable	160
MSV000094097	Pool_blood_plasma_2.mzML	animal	biofluid	9606|Homo sapiens	2023	blood draw, venous	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected						not applicable		not applicable	161
MSV000094097	Pool_blood_plasma_3.mzML	animal	biofluid	9606|Homo sapiens	2023	blood draw, venous	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected						not applicable		not applicable	162
MSV000094097	Pool_blood_plasma_4.mzML	animal	biofluid	9606|Homo sapiens	2023	blood draw, venous	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected						not applicable		not applicable	163
MSV000094097	Pool_blood_plasma_5.mzML	animal	biofluid	9606|Homo sapiens	2023	blood draw, venous	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected						not applicable		not applicable	164
MSV000094097	Pool_blood_plasma_6.mzML	animal	biofluid	9606|Homo sapiens	2023	blood draw, venous	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected						not applicable		not applicable	165
MSV000094097	Pool_blood_plasma_7.mzML	animal	biofluid	9606|Homo sapiens	2023	blood draw, venous	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected						not applicable		not applicable	166
MSV000094097	Pool_blood_plasma_8.mzML	animal	biofluid	9606|Homo sapiens	2023	blood draw, venous	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected						not applicable		not applicable	167
MSV000094097	Pool_blood_serum_1.mzML	animal	biofluid	9606|Homo sapiens	2023	blood draw, venous	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected						not applicable		not applicable	168
MSV000094097	Pool_blood_serum_2.mzML	animal	biofluid	9606|Homo sapiens	2023	blood draw, venous	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected						not applicable		not applicable	169
MSV000094097	Pool_blood_serum_3.mzML	animal	biofluid	9606|Homo sapiens	2023	blood draw, venous	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected						not applicable		not applicable	170
MSV000094097	Pool_blood_serum_4.mzML	animal	biofluid	9606|Homo sapiens	2023	blood draw, venous	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected						not applicable		not applicable	171
MSV000094097	Pool_blood_serum_5.mzML	animal	biofluid	9606|Homo sapiens	2023	blood draw, venous	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected						not applicable		not applicable	172
MSV000094097	Pool_blood_serum_6.mzML	animal	biofluid	9606|Homo sapiens	2023	blood draw, venous	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected						not applicable		not applicable	173
MSV000094097	Pool_blood_serum_7.mzML	animal	biofluid	9606|Homo sapiens	2023	blood draw, venous	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected						not applicable		not applicable	174
MSV000094097	Pool_blood_serum_8.mzML	animal	biofluid	9606|Homo sapiens	2023	blood draw, venous	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected						not applicable		not applicable	175
MSV000094097	Pool_blood_serum_9.mzML	animal	biofluid	9606|Homo sapiens	2023	blood draw, venous	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected						not applicable		not applicable	176
MSV000094097	pool_saliva_1_prot2.mzML	animal	biofluid	9606|Homo sapiens	2023	liquid	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected						not applicable		not applicable	177
MSV000094097	pool_saliva_2_prot2.mzML	animal	biofluid	9606|Homo sapiens	2023	liquid	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected						not applicable		not applicable	178
MSV000094097	pool_saliva_3_prot2.mzML	animal	biofluid	9606|Homo sapiens	2023	liquid	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected						not applicable		not applicable	179
MSV000094097	pool_saliva_4_prot2.mzML	animal	biofluid	9606|Homo sapiens	2023	liquid	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected						not applicable		not applicable	180
MSV000094097	pool_saliva_5_prot2.mzML	animal	biofluid	9606|Homo sapiens	2023	liquid	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected						not applicable		not applicable	181
MSV000094097	pool_saliva_6_prot2.mzML	animal	biofluid	9606|Homo sapiens	2023	liquid	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected						not applicable		not applicable	182
MSV000094097	pool_saliva_7_prot2.mzML	animal	biofluid	9606|Homo sapiens	2023	liquid	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected						not applicable		not applicable	183
MSV000094097	pool_stool_1.mzML	animal	biofluid	9606|Homo sapiens	2023	swabs, solution (100% EtOH)	ethanol-water (1:1)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected						not applicable		not applicable	184
MSV000094097	pool_stool_2.mzML	animal	biofluid	9606|Homo sapiens	2023	swabs, solution (100% EtOH)	ethanol-water (1:1)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected						not applicable		not applicable	185
MSV000094097	pool_stool_3.mzML	animal	biofluid	9606|Homo sapiens	2023	swabs, solution (100% EtOH)	ethanol-water (1:1)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected						not applicable		not applicable	186
MSV000094097	pool_stool_4.mzML	animal	biofluid	9606|Homo sapiens	2023	swabs, solution (100% EtOH)	ethanol-water (1:1)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected						not applicable		not applicable	187
MSV000094097	pool_stool_5.mzML	animal	biofluid	9606|Homo sapiens	2023	swabs, solution (100% EtOH)	ethanol-water (1:1)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected						not applicable		not applicable	188
MSV000094097	pool_stool_6.mzML	animal	biofluid	9606|Homo sapiens	2023	swabs, solution (100% EtOH)	ethanol-water (1:1)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected						not applicable		not applicable	189
MSV000094097	QC_saliva_1_prot2.mzML	blank_QC	blank_QC	not applicable	2023	not applicable	methanol-water (1:1)	sulfamethizole;sulfachloropyridazine;sulfadimethoxine;sulfamethazine;coumarin-314;amitryptiline	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	not applicable	not applicable	not applicable		United States of America	not collected						not applicable	not applicable	not applicable	190
MSV000094097	QC_saliva_2_prot2.mzML	blank_QC	blank_QC	not applicable	2023	not applicable	methanol-water (1:1)	sulfamethizole;sulfachloropyridazine;sulfadimethoxine;sulfamethazine;coumarin-314;amitryptiline	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	not applicable	not applicable	not applicable		United States of America	not collected						not applicable	not applicable	not applicable	191
MSV000094097	QC_saliva_3_prot2.mzML	blank_QC	blank_QC	not applicable	2023	not applicable	methanol-water (1:1)	sulfamethizole;sulfachloropyridazine;sulfadimethoxine;sulfamethazine;coumarin-314;amitryptiline	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	not applicable	not applicable	not applicable		United States of America	not collected						not applicable	not applicable	not applicable	192
MSV000094097	QC_saliva_4_prot2.mzML	blank_QC	blank_QC	not applicable	2023	not applicable	methanol-water (1:1)	sulfamethizole;sulfachloropyridazine;sulfadimethoxine;sulfamethazine;coumarin-314;amitryptiline	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	not applicable	not applicable	not applicable		United States of America	not collected						not applicable	not applicable	not applicable	193
MSV000094097	QC_saliva_5_prot2.mzML	blank_QC	blank_QC	not applicable	2023	not applicable	methanol-water (1:1)	sulfamethizole;sulfachloropyridazine;sulfadimethoxine;sulfamethazine;coumarin-314;amitryptiline	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	not applicable	not applicable	not applicable		United States of America	not collected						not applicable	not applicable	not applicable	194
MSV000094097	QC_saliva_6_prot2.mzML	blank_QC	blank_QC	not applicable	2023	not applicable	methanol-water (1:1)	sulfamethizole;sulfachloropyridazine;sulfadimethoxine;sulfamethazine;coumarin-314;amitryptiline	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	not applicable	not applicable	not applicable		United States of America	not collected						not applicable	not applicable	not applicable	195
MSV000094097	QC_saliva_7_prot2.mzML	blank_QC	blank_QC	not applicable	2023	not applicable	methanol-water (1:1)	sulfamethizole;sulfachloropyridazine;sulfadimethoxine;sulfamethazine;coumarin-314;amitryptiline	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	not applicable	not applicable	not applicable		United States of America	not collected						not applicable	not applicable	not applicable	196
MSV000094097	QC_saliva_8_prot2.mzML	blank_QC	blank_QC	not applicable	2023	not applicable	methanol-water (1:1)	sulfamethizole;sulfachloropyridazine;sulfadimethoxine;sulfamethazine;coumarin-314;amitryptiline	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	not applicable	not applicable	not applicable		United States of America	not collected						not applicable	not applicable	not applicable	197
MSV000094097	QC_blood_1.mzML	blank_QC	blank_QC	not applicable	2023	not applicable	methanol-water (1:1)	sulfamethizole;sulfachloropyridazine;sulfadimethoxine;sulfamethazine;coumarin-314;amitryptiline	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	not applicable	not applicable	not applicable		United States of America	not collected						not applicable	not applicable	not applicable	198
MSV000094097	QC_blood_2.mzML	blank_QC	blank_QC	not applicable	2023	not applicable	methanol-water (1:1)	sulfamethizole;sulfachloropyridazine;sulfadimethoxine;sulfamethazine;coumarin-314;amitryptiline	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	not applicable	not applicable	not applicable		United States of America	not collected						not applicable	not applicable	not applicable	199
MSV000094097	QC_blood_3.mzML	blank_QC	blank_QC	not applicable	2023	not applicable	methanol-water (1:1)	sulfamethizole;sulfachloropyridazine;sulfadimethoxine;sulfamethazine;coumarin-314;amitryptiline	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	not applicable	not applicable	not applicable		United States of America	not collected						not applicable	not applicable	not applicable	200
MSV000094097	QC_blood_4.mzML	blank_QC	blank_QC	not applicable	2023	not applicable	methanol-water (1:1)	sulfamethizole;sulfachloropyridazine;sulfadimethoxine;sulfamethazine;coumarin-314;amitryptiline	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	not applicable	not applicable	not applicable		United States of America	not collected						not applicable	not applicable	not applicable	201
MSV000094097	QC_blood_5.mzML	blank_QC	blank_QC	not applicable	2023	not applicable	methanol-water (1:1)	sulfamethizole;sulfachloropyridazine;sulfadimethoxine;sulfamethazine;coumarin-314;amitryptiline	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	not applicable	not applicable	not applicable		United States of America	not collected						not applicable	not applicable	not applicable	202
MSV000094097	QC_blood_6.mzML	blank_QC	blank_QC	not applicable	2023	not applicable	methanol-water (1:1)	sulfamethizole;sulfachloropyridazine;sulfadimethoxine;sulfamethazine;coumarin-314;amitryptiline	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	not applicable	not applicable	not applicable		United States of America	not collected						not applicable	not applicable	not applicable	203
MSV000094097	QC_blood_7.mzML	blank_QC	blank_QC	not applicable	2023	not applicable	methanol-water (1:1)	sulfamethizole;sulfachloropyridazine;sulfadimethoxine;sulfamethazine;coumarin-314;amitryptiline	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	not applicable	not applicable	not applicable		United States of America	not collected						not applicable	not applicable	not applicable	204
MSV000094097	QC_blood_8.mzML	blank_QC	blank_QC	not applicable	2023	not applicable	methanol-water (1:1)	sulfamethizole;sulfachloropyridazine;sulfadimethoxine;sulfamethazine;coumarin-314;amitryptiline	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	not applicable	not applicable	not applicable		United States of America	not collected						not applicable	not applicable	not applicable	205
MSV000094097	QC_blood_9.mzML	blank_QC	blank_QC	not applicable	2023	not applicable	methanol-water (1:1)	sulfamethizole;sulfachloropyridazine;sulfadimethoxine;sulfamethazine;coumarin-314;amitryptiline	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	not applicable	not applicable	not applicable		United States of America	not collected						not applicable	not applicable	not applicable	206
MSV000094097	QC_blood_10.mzML	blank_QC	blank_QC	not applicable	2023	not applicable	methanol-water (1:1)	sulfamethizole;sulfachloropyridazine;sulfadimethoxine;sulfamethazine;coumarin-314;amitryptiline	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	not applicable	not applicable	not applicable		United States of America	not collected						not applicable	not applicable	not applicable	207
MSV000094097	QC_blood_11.mzML	blank_QC	blank_QC	not applicable	2023	not applicable	methanol-water (1:1)	sulfamethizole;sulfachloropyridazine;sulfadimethoxine;sulfamethazine;coumarin-314;amitryptiline	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	not applicable	not applicable	not applicable		United States of America	not collected						not applicable	not applicable	not applicable	208
MSV000094097	QC_blood_12.mzML	blank_QC	blank_QC	not applicable	2023	not applicable	methanol-water (1:1)	sulfamethizole;sulfachloropyridazine;sulfadimethoxine;sulfamethazine;coumarin-314;amitryptiline	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	not applicable	not applicable	not applicable		United States of America	not collected						not applicable	not applicable	not applicable	209
MSV000094097	QC_blood_13.mzML	blank_QC	blank_QC	not applicable	2023	not applicable	methanol-water (1:1)	sulfamethizole;sulfachloropyridazine;sulfadimethoxine;sulfamethazine;coumarin-314;amitryptiline	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	not applicable	not applicable	not applicable		United States of America	not collected						not applicable	not applicable	not applicable	210
MSV000094097	QC_blood_14.mzML	blank_QC	blank_QC	not applicable	2023	not applicable	methanol-water (1:1)	sulfamethizole;sulfachloropyridazine;sulfadimethoxine;sulfamethazine;coumarin-314;amitryptiline	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	not applicable	not applicable	not applicable		United States of America	not collected						not applicable	not applicable	not applicable	211
MSV000094097	QC_blood_15.mzML	blank_QC	blank_QC	not applicable	2023	not applicable	methanol-water (1:1)	sulfamethizole;sulfachloropyridazine;sulfadimethoxine;sulfamethazine;coumarin-314;amitryptiline	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	not applicable	not applicable	not applicable		United States of America	not collected						not applicable	not applicable	not applicable	212
MSV000094097	QC_blood_16.mzML	blank_QC	blank_QC	not applicable	2023	not applicable	methanol-water (1:1)	sulfamethizole;sulfachloropyridazine;sulfadimethoxine;sulfamethazine;coumarin-314;amitryptiline	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	not applicable	not applicable	not applicable		United States of America	not collected						not applicable	not applicable	not applicable	213
MSV000094097	QC_blood_17.mzML	blank_QC	blank_QC	not applicable	2023	not applicable	methanol-water (1:1)	sulfamethizole;sulfachloropyridazine;sulfadimethoxine;sulfamethazine;coumarin-314;amitryptiline	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	not applicable	not applicable	not applicable		United States of America	not collected						not applicable	not applicable	not applicable	214
MSV000094097	QC_blood_18.mzML	blank_QC	blank_QC	not applicable	2023	not applicable	methanol-water (1:1)	sulfamethizole;sulfachloropyridazine;sulfadimethoxine;sulfamethazine;coumarin-314;amitryptiline	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	not applicable	not applicable	not applicable		United States of America	not collected						not applicable	not applicable	not applicable	215
MSV000094097	QC_stool_1.mzML	blank_QC	blank_QC	not applicable	2023	not applicable	methanol-water (1:1)	sulfamethizole;sulfachloropyridazine;sulfadimethoxine;sulfamethazine;coumarin-314;amitryptiline	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	not applicable	not applicable	not applicable		United States of America	not collected						not applicable	not applicable	not applicable	216
MSV000094097	QC_stool_2.mzML	blank_QC	blank_QC	not applicable	2023	not applicable	methanol-water (1:1)	sulfamethizole;sulfachloropyridazine;sulfadimethoxine;sulfamethazine;coumarin-314;amitryptiline	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	not applicable	not applicable	not applicable		United States of America	not collected						not applicable	not applicable	not applicable	217
MSV000094097	QC_stool_3.mzML	blank_QC	blank_QC	not applicable	2023	not applicable	methanol-water (1:1)	sulfamethizole;sulfachloropyridazine;sulfadimethoxine;sulfamethazine;coumarin-314;amitryptiline	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	not applicable	not applicable	not applicable		United States of America	not collected						not applicable	not applicable	not applicable	218
MSV000094097	QC_stool_4.mzML	blank_QC	blank_QC	not applicable	2023	not applicable	methanol-water (1:1)	sulfamethizole;sulfachloropyridazine;sulfadimethoxine;sulfamethazine;coumarin-314;amitryptiline	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	not applicable	not applicable	not applicable		United States of America	not collected						not applicable	not applicable	not applicable	219
MSV000094097	QC_stool_5.mzML	blank_QC	blank_QC	not applicable	2023	not applicable	methanol-water (1:1)	sulfamethizole;sulfachloropyridazine;sulfadimethoxine;sulfamethazine;coumarin-314;amitryptiline	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	not applicable	not applicable	not applicable		United States of America	not collected						not applicable	not applicable	not applicable	220
MSV000094097	QC_stool_6.mzML	blank_QC	blank_QC	not applicable	2023	not applicable	methanol-water (1:1)	sulfamethizole;sulfachloropyridazine;sulfadimethoxine;sulfamethazine;coumarin-314;amitryptiline	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	not applicable	not applicable	not applicable		United States of America	not collected						not applicable	not applicable	not applicable	221
MSV000094097	QC_stool_7.mzML	blank_QC	blank_QC	not applicable	2023	not applicable	methanol-water (1:1)	sulfamethizole;sulfachloropyridazine;sulfadimethoxine;sulfamethazine;coumarin-314;amitryptiline	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	not applicable	not applicable	not applicable		United States of America	not collected						not applicable	not applicable	not applicable	222
MSV000094097	QC_stool_8.mzML	blank_QC	blank_QC	not applicable	2023	not applicable	methanol-water (1:1)	sulfamethizole;sulfachloropyridazine;sulfadimethoxine;sulfamethazine;coumarin-314;amitryptiline	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)			not applicable	not applicable	not applicable	not applicable	not applicable	not applicable		United States of America	not collected						not applicable	not applicable	not applicable	223
MSV000094097	VAOAD_001_Basal_P.mzML	animal	biofluid	9606|Homo sapiens	2023	blood draw, venous	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		72.0	male	blood plasma	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Later Adulthood (>65 yrs)	UBERON:0001969		Before	224
MSV000094097	VAOAD_001_Basal_S.mzML	animal	biofluid	9606|Homo sapiens	2023	blood draw, venous	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		72.0	male	blood serum	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Later Adulthood (>65 yrs)	UBERON:0001977		Before	225
MSV000094097	VAOAD_001_Day15_P.mzML	animal	biofluid	9606|Homo sapiens	2023	blood draw, venous	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		72.0	male	blood plasma	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Later Adulthood (>65 yrs)	UBERON:0001969		After	226
MSV000094097	VAOAD_001_Day15_S.mzML	animal	biofluid	9606|Homo sapiens	2023	blood draw, venous	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		72.0	male	blood serum	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Later Adulthood (>65 yrs)	UBERON:0001977		After	227
MSV000094097	VAOAD_002_Basal_P.mzML	animal	biofluid	9606|Homo sapiens	2023	blood draw, venous	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		72.0	female	blood plasma	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Later Adulthood (>65 yrs)	UBERON:0001969		Before	228
MSV000094097	VAOAD_002_Basal_S.mzML	animal	biofluid	9606|Homo sapiens	2023	blood draw, venous	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		72.0	female	blood serum	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Later Adulthood (>65 yrs)	UBERON:0001977		Before	229
MSV000094097	VAOAD_002_Day15_P.mzML	animal	biofluid	9606|Homo sapiens	2023	blood draw, venous	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		72.0	female	blood plasma	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Later Adulthood (>65 yrs)	UBERON:0001969		After	230
MSV000094097	VAOAD_002_Day15_S.mzML	animal	biofluid	9606|Homo sapiens	2023	blood draw, venous	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		72.0	female	blood serum	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Later Adulthood (>65 yrs)	UBERON:0001977		After	231
MSV000094097	VAOAD_004_Basal_P.mzML	animal	biofluid	9606|Homo sapiens	2023	blood draw, venous	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		55.0	female	blood plasma	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969		Before	232
MSV000094097	VAOAD_004_Basal_S.mzML	animal	biofluid	9606|Homo sapiens	2023	blood draw, venous	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		55.0	female	blood serum	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001977		Before	233
MSV000094097	VAOAD_004_Day15_P.mzML	animal	biofluid	9606|Homo sapiens	2023	blood draw, venous	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		55.0	female	blood plasma	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969		After	234
MSV000094097	VAOAD_004_Day15_S.mzML	animal	biofluid	9606|Homo sapiens	2023	blood draw, venous	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		55.0	female	blood serum	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001977		After	235
MSV000094097	VAOAD_008_Basal_P.mzML	animal	biofluid	9606|Homo sapiens	2023	blood draw, venous	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		73.0	male	blood plasma	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Later Adulthood (>65 yrs)	UBERON:0001969		Before	236
MSV000094097	VAOAD_008_Basal_S.mzML	animal	biofluid	9606|Homo sapiens	2023	blood draw, venous	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		73.0	male	blood serum	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Later Adulthood (>65 yrs)	UBERON:0001977		Before	237
MSV000094097	VAOAD_008_Day15_P.mzML	animal	biofluid	9606|Homo sapiens	2023	blood draw, venous	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		73.0	male	blood plasma	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Later Adulthood (>65 yrs)	UBERON:0001969		After	238
MSV000094097	VAOAD_008_Day15_S.mzML	animal	biofluid	9606|Homo sapiens	2023	blood draw, venous	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		73.0	male	blood serum	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Later Adulthood (>65 yrs)	UBERON:0001977		After	239
MSV000094097	VAOAD_009_Basal_P.mzML	animal	biofluid	9606|Homo sapiens	2023	blood draw, venous	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		71.0	male	blood plasma	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Later Adulthood (>65 yrs)	UBERON:0001969		Before	240
MSV000094097	VAOAD_009_Basal_S.mzML	animal	biofluid	9606|Homo sapiens	2023	blood draw, venous	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		71.0	male	blood serum	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Later Adulthood (>65 yrs)	UBERON:0001977		Before	241
MSV000094097	VAOAD_009_Day15_P.mzML	animal	biofluid	9606|Homo sapiens	2023	blood draw, venous	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		71.0	male	blood plasma	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Later Adulthood (>65 yrs)	UBERON:0001969		After	242
MSV000094097	VAOAD_009_Day15_S.mzML	animal	biofluid	9606|Homo sapiens	2023	blood draw, venous	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		71.0	male	blood serum	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Later Adulthood (>65 yrs)	UBERON:0001977		After	243
MSV000094097	VAOAD_010_Basal_P.mzML	animal	biofluid	9606|Homo sapiens	2023	blood draw, venous	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		50.0	male	blood plasma	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969		Before	244
MSV000094097	VAOAD_010_Basal_S.mzML	animal	biofluid	9606|Homo sapiens	2023	blood draw, venous	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		50.0	male	blood serum	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001977		Before	245
MSV000094097	VAOAD_010_Day15_P.mzML	animal	biofluid	9606|Homo sapiens	2023	blood draw, venous	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		50.0	male	blood plasma	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969		After	246
MSV000094097	VAOAD_010_Day15_S.mzML	animal	biofluid	9606|Homo sapiens	2023	blood draw, venous	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		50.0	male	blood serum	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001977		After	247
MSV000094097	VAOAD_011_Basal_P.mzML	animal	biofluid	9606|Homo sapiens	2023	blood draw, venous	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		51.0	male	blood plasma	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969		Before	248
MSV000094097	VAOAD_011_Basal_S.mzML	animal	biofluid	9606|Homo sapiens	2023	blood draw, venous	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		51.0	male	blood serum	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001977		Before	249
MSV000094097	VAOAD_011_Day15_P.mzML	animal	biofluid	9606|Homo sapiens	2023	blood draw, venous	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		51.0	male	blood plasma	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969		After	250
MSV000094097	VAOAD_011_Day15_S.mzML	animal	biofluid	9606|Homo sapiens	2023	blood draw, venous	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		51.0	male	blood serum	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001977		After	251
MSV000094097	VAOAD_012_Basal_P.mzML	animal	biofluid	9606|Homo sapiens	2023	blood draw, venous	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		68.0	male	blood plasma	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Later Adulthood (>65 yrs)	UBERON:0001969		Before	252
MSV000094097	VAOAD_012_Basal_S.mzML	animal	biofluid	9606|Homo sapiens	2023	blood draw, venous	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		68.0	male	blood serum	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Later Adulthood (>65 yrs)	UBERON:0001977		Before	253
MSV000094097	VAOAD_012_Day15_P.mzML	animal	biofluid	9606|Homo sapiens	2023	blood draw, venous	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		68.0	male	blood plasma	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Later Adulthood (>65 yrs)	UBERON:0001969		After	254
MSV000094097	VAOAD_012_Day15_S.mzML	animal	biofluid	9606|Homo sapiens	2023	blood draw, venous	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		68.0	male	blood serum	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Later Adulthood (>65 yrs)	UBERON:0001977		After	255
MSV000094097	VAOAD_014_Basal_P.mzML	animal	biofluid	9606|Homo sapiens	2023	blood draw, venous	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		76.0	male	blood plasma	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Later Adulthood (>65 yrs)	UBERON:0001969		Before	256
MSV000094097	VAOAD_014_Basal_S.mzML	animal	biofluid	9606|Homo sapiens	2023	blood draw, venous	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		76.0	male	blood serum	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Later Adulthood (>65 yrs)	UBERON:0001977		Before	257
MSV000094097	VAOAD_014_Day15_P.mzML	animal	biofluid	9606|Homo sapiens	2023	blood draw, venous	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		76.0	male	blood plasma	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Later Adulthood (>65 yrs)	UBERON:0001969		After	258
MSV000094097	VAOAD_014_Day15_S.mzML	animal	biofluid	9606|Homo sapiens	2023	blood draw, venous	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		76.0	male	blood serum	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Later Adulthood (>65 yrs)	UBERON:0001977		After	259
MSV000094097	VAOAD_015_Basal_P.mzML	animal	biofluid	9606|Homo sapiens	2023	blood draw, venous	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		65.0	not collected	blood plasma	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969		Before	260
MSV000094097	VAOAD_015_Basal_S.mzML	animal	biofluid	9606|Homo sapiens	2023	blood draw, venous	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		65.0	not collected	blood serum	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001977		Before	261
MSV000094097	VAOAD_015_Day15_P.mzML	animal	biofluid	9606|Homo sapiens	2023	blood draw, venous	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		65.0	not collected	blood plasma	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001969		After	262
MSV000094097	VAOAD_015_Day15_S.mzML	animal	biofluid	9606|Homo sapiens	2023	blood draw, venous	methanol (100%)	sulfadimethoxine	Q Exactive|MS:1001911	electrospray ionization (positive)	reverse phase (C18)		65.0	not collected	blood serum	not applicable	chronic illness	osteoarthritis	not applicable		United States of America	not collected					Middle Adulthood (45 yrs < x <= 65 yrs)	UBERON:0001977		After	263
